Man Group
DTIL icon

Man Group’s Precision BioSciences DTIL Stock Holding History

Man Group’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-775
Closed -$27.7K – 2115
2022
Q4 		$27.7K Sell
775
-3,300
-81% -$130K ﹤0.01% 1972
2022
Q3 		$159K Buy
+4,075
New +$194K ﹤0.01% 1804
2022
Q2 		– Sell
-693
Closed -$64K – 2145
2022
Q1 		$64K Buy
+693
New +$94.2K ﹤0.01% 2105
2021
Q1 		– Sell
-1,977
Closed -$495K – 1886
2020
Q4 		$495K Sell
1,977
-526
-21% -$129K ﹤0.01% 1557
2020
Q3 		$463K Buy
2,503
+1,368
+121% +$272K ﹤0.01% 1558
2020
Q2 		$284K Buy
+1,135
New +$249K ﹤0.01% 1555

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Man Group's DTIL Position: Q1 2023 in Review

Man Group sold out of Precision BioSciences (DTIL) in Q1 2023, closing a stake of 775 shares — an estimated $27.7K sold.

Man Group first reported a position in DTIL in Q2 2020 and held it in 6 quarters. The position peaked at $495K in Q4 2020. 86 funds tracked by Wall St. Rank hold DTIL as of Q1 2023.

  • Man Group reported no remaining Precision BioSciences position as of Q1 2023 after selling out during the quarter.
  • Man Group sold 775 Precision BioSciences shares in Q1 2023, an estimated $27.7K.
  • Man Group first reported a position in Precision BioSciences in Q2 2020 and held it in 6 quarters.
  • Man Group's Precision BioSciences position peaked at $495K in Q4 2020.
  • 86 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.